Back to CVE records
High 7.4Published Oct 8, 2026

CVE-2026-107720fast-jwt: createVerifier accepts unsigned JWTs when key is '' or null and algorithms is explicitly set

Updated under an hour ago ()

Does this affect you?

It affects nearform fast-jwt. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.26%, higher than 16% of scored CVEs.

fast-jwt provides fast JSON Web Token (JWT) implementation. Prior to 6.3.1, fast-jwt createVerifier accepts an unsigned JWT when key is an empty string or null and algorithms is a non-empty allowlist. Falsy synchronous keys bypass prepareKeyOrSecret, allowedAlgorithms remains active, hasKey is false, and the empty signature avoids the verifySignature gate. An attacker can therefore submit a token containing arbitrary claims without possessing a signing key, resulting in authentication or authorization bypass. Claim validators still run, and non-empty keys, an empty key without algorithms, and the async key resolver path do not have this behavior. This issue is fixed in version 6.3.1.

CVSS
7.4 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:N
Weakness (CWE)
CWE-20, CWE-347
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.26% (percentile 16)
Assigned by
GitHub_M
NVD analysis
Deferred
Record last updated
Oct 9, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
nearform fast-jwt
nearform:fast_jwt (from the name)
before 6.3.1
CNA record

References

  • x-refsource-confirm
  • x-refsource-misc
  • x-refsource-misc
  • x-refsource-misc

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.